Vir Biotechnology, Inc. Common Stock (VIR)
Vir Biotechnology's stock faces pressure from upcoming Q1 [----] financial results, overshadowing positive news in hepatitis treatment trials and acquisition rumors. Social sentiment is mixed, with immediate focus on financial concerns despite long-term catalyst discussions.
About Vir Biotechnology, Inc. Common Stock
Vir Biotechnology, Inc. is a biotechnology company focused on developing treatments for serious infectious diseases.
Vir Biotechnology, Inc. Common Stock uses the ticker $VIR for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Vir Biotechnology, Inc. Common Stock (VIR) social dominance is up 90% from the previous week.
- Vir Biotechnology, Inc. Common Stock (VIR) creators is up 42.86% from the previous month.
- Vir Biotechnology, Inc. Common Stock (VIR) mentions is up 48.25% from the previous month.
- Vir Biotechnology, Inc. Common Stock (VIR) posts created is up 92.21% from the previous month.
Price: $7.50
Price 24-Hour Time-Series Raw Data
The stock price has declined by 8.09% in the last [--] hours, primarily driven by concerns over upcoming Q1 [----] financial results, which are outweighing positive developments in hepatitis treatment trials and acquisition rumors. Social media sentiment is mixed, with some supportive posts about long-term catalysts, but the immediate focus remains on financial concerns.
24-Hour: -4.11% 7-Day: 1.08% 30-Day: 23.27%
1-Year High: $9.90 on 2025-02-19
1-Year Low: $4.30 on 2025-08-11
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Vir Biotechnology, Inc. Common Stock (VIR) is currently AltRank #2,021 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] +115
[--] Month: [-----] +1,702
[--] Months: [-----] +1,210
[--] Year: [-----] +1,251
1-Year High: [-----] on 2025-09-13
1-Year Low: [--] on 2025-11-02
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +3
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-08-27
1-Year Low: [--] on 2025-07-18
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] -38%
[--] Month: [-------] +177%
[--] Months: [-------] -20%
[--] Year: [---------] -48%
1-Year High: [------] on 2025-08-27
1-Year Low: [---] on 2025-10-15
Engagements by network (24h): X: [---] Reddit: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +13%
[--] Month: [---] +48%
[--] Months: [-----] -40%
[--] Year: [-----] -1.70%
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-10-28
Mentions by network (24h): X: [--] Reddit: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Vir Biotechnology, Inc. Common Stock (VIR) in the last [--] hours which is down 23% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +15%
[--] Month: [---] +43%
[--] Months: [---] -55%
[--] Year: [-----] +28%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-28
The most influential creators that mention Vir Biotechnology, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @DeepSouthDoctor | [--] | [-----] | [--] | [--] |
| @GeppL86215 | [--] | [--] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
Sentiment: 50%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 50%
Daily Average: 66%
[--] Week: 25% -25%
[--] Month: 38% -10%
[--] Months: 38% -62%
[--] Year: 38% -53%
1-Year High: 100% on 2025-02-17
1-Year Low: 7% on 2025-12-14
Most Supportive Themes:
- Hepatitis Treatment Trials: (30%) Vir Biotechnology is developing treatments for infectious diseases, including advancements in hepatitis treatment.
- Acquisition Rumors: (25%) There are ongoing discussions and speculation regarding potential acquisitions involving Vir Biotechnology.
Most Critical Themes:
- Q1 [----] Financial Results: (45%) Concerns over the upcoming Q1 [----] financial results are impacting the stock's performance.
Social Dominance: 0.00281%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00281%
Daily Average: 0.00762%
[--] Week: 0.00285% +0.00135%
[--] Month: 0.0036% -0.0027%
[--] Months: 0.0036% -0.002%
[--] Year: 0.0036% -0.0078%
1-Year High: 0.036% on 2025-06-30
1-Year Low: 0.0008% on 2025-10-28
Market Dominance: 0.00116%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00116%
Daily Average: 0%
1-Year High: 0.039% on 2025-03-11
1-Year Low: 0.00076% on 2025-08-11
Market Cap: $1,026,742,736
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,026,742,736
Daily Average: $819,993,610
[--] Week: $1,026,742,736 +1.70%
[--] Month: $1,039,263,989 +23%
[--] Months: $1,039,263,989 +72%
[--] Year: $1,039,263,989 -22%
1-Year High: $1,350,861,367 on 2025-02-19
1-Year Low: $594,562,303 on 2025-08-11
Top Vir Biotechnology, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"this work of art ended up being meh and you think your favorite TCE-in-solid-tumor wont be Why what TCE problem does theirs cover that this doesn't "dosing regimen" lipstick on a pig. $CNTX $VIR $JANX"
X Link @RiskInhibitor 2026-02-14T21:20Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing